How can we prevent and treat pre-diabetes? Can a pill delay or prevent the onset of disease in high-risk individuals? Host Dr. Steven Edelman talks to Dr. Sunder Mudaliar, clinical professor of medicine in the division of endocrinology and metabolsim at the VA Medical Center and University of California San Diego School of Medicine, about the data on pioglitazone for diabetes prevention and the results of the ACT NOW study.
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
How can we prevent and treat pre-diabetes? Can a pill delay or prevent the onset of disease in high-risk individuals? Host Dr. Steven Edelman talks to Dr. Sunder Mudaliar, clinical professor of medicine in the division of endocrinology and metabolsim at the VA Medical Center and University of California San Diego School of Medicine, about the data on pioglitazone for diabetes prevention and the results of the ACT NOW study.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?